FDA

Mesothelioma Cancer Cardio AIDS
Alternative Medicine Biotechnology Clinical Trials
Dental Diabetes FDA
Fitness & Nutrition Genetics Hospitals
Infectious Diseases Medical Devices Medical Supplies
Mental Health Nursing Oncology
Optical Pharmaceutical Radiology
Veterinary
February 09, 2012 04:37
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals announced that it was informed this evening that the FDA will not schedule an advisory committee meeting in connection with the its review of the llinaclotide NDA.
World  World      FDA  FDA